Carta Revisado por pares

Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants

2023; American Medical Association; Volume: 178; Issue: 2 Linguagem: Inglês

10.1001/jamapediatrics.2023.5639

ISSN

2168-6211

Autores

Leila C. Sahni, Samantha M. Olson, Natasha Halasa, Laura S Stewart, Marian G. Michaels, John V. Williams, Janet A. Englund, Eileen J. Klein, Mary Allen Staat, Elizabeth P. Schlaudecker, Rangaraj Selvarangan, Jennifer E. Schuster, Geoffrey A. Weinberg, Peter G. Szilagyi, Julie A. Boom, Manish M. Patel, Flor M. Muñoz, Monica McNeal, Chelsea Rohlfs, Miranda Howard, Vasanthi Avadhanula, Pedro A. Piedra, Christopher J. Harrison, Mary E. Moffat, Gina Weddle, Robert W. Hickey, Judith M. Martin, Karine Lacombe, Hanna Schlaack, Bonnie Strelitz,

Tópico(s)

Respiratory viral infections research

Resumo

Influenza virus infection during pregnancy is associated with severe maternal disease and may be associated with adverse birth outcomes. Inactivated influenza vaccine during pregnancy is safe and effective and can protect young infants, but recent evidence, particularly after the 2009 novel influenza A (H1N1) pandemic, is limited.

Referência(s)
Altmetric
PlumX